These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3967568)

  • 1. Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.
    Davis GL; Czaja AJ; Taswell HF; Ludwig J; Go VL
    Dig Dis Sci; 1985 Feb; 30(2):97-103. PubMed ID: 3967568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.
    Hadziyannis SJ; Lieberman HM; Karvountzis GG; Shafritz DA
    Hepatology; 1983; 3(5):656-62. PubMed ID: 6618432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR; Czaja AJ; Taswell HF; Ludwig J; Rakela J; Chase R
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection.
    Hsu HC; Su IJ; Lai MY; Chen DS; Chang MH; Chuang SM; Sung JL
    J Hepatol; 1987 Aug; 5(1):45-50. PubMed ID: 3655309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis.
    Sagnelli E; Manzillo G; Maio G; Pasquale G; Felaco FM; Filippini P; Izzo CM; Piccinino F
    Lancet; 1980 Aug; 2(8191):395-7. PubMed ID: 6105519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg-positive chronic liver disease.
    Pontisso P; Chemello L; Fattovich G; Alberti A; Realdi G; Brechot C
    J Med Virol; 1985 Oct; 17(2):145-52. PubMed ID: 4056756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dane particle-associated hepatitis B e antigen in patients with chronic hepatitis B virus infection and hepatitis B e antibody.
    Raimondo G; Recchia S; Lavarini C; Crivelli O; Rizzetto M
    Hepatology; 1982; 2(4):449-54. PubMed ID: 7095745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum HBV DNA and intrahepatic hepatitis B core antigen (HBcAg) in chronic hepatitis B virus infection: correlation with infectivity and liver histology.
    Milani S; Ambu S; Patussi V; D'Agata A; Labardi M; Salvadori G; Surrenti C
    Hepatogastroenterology; 1988 Dec; 35(6):306-8. PubMed ID: 3215627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic persistent hepatitis B. Relationship between hepatitis B virus replication and the course of the disease.
    Sánchez-Tapias JM; Vilar JH; Costa J; Bruguera M; Ballesta AM; Rodés J
    J Hepatol; 1985; 1(1):15-27. PubMed ID: 4056339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies.
    Mondelli M; Tedder RS; Ferns B; Pontisso P; Realdi G; Alberti A
    Hepatology; 1986; 6(2):199-204. PubMed ID: 3514406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.
    Wu JC; Lee SD; Wang JY; Ting LP; Tsai YT; Tsay SH; Tong MJ
    Arch Pathol Lab Med; 1987 Feb; 111(2):181-4. PubMed ID: 3545139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
    Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
    World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum and hepatic markers of hepatitis B viral infection in HBsAg-positive and HBsAg-negative chronic active hepatitis.
    Freiman J; Eckstein R; McCaughan G; Parsons C; Davies JS; Diegutis P; Burnett L; Gallagher N
    Hepatology; 1985; 5(1):50-3. PubMed ID: 3855403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and significance of immunoglobulin M antibody to hepatitis B core antigen in corticosteroid-treated severe chronic active hepatitis B.
    Czaja AJ; Shiels MT; Taswell HF; Wood JR; Ludwig J; Chase RC
    Mayo Clin Proc; 1988 Feb; 63(2):119-25. PubMed ID: 3339905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation.
    Möller B; Hopf U; Stemerowicz R; Henze G; Gelderblom H
    Hepatology; 1989 Aug; 10(2):179-85. PubMed ID: 2744730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis.
    Sagnelli E; Felaco FM; Pasquale G; Filippini P; Piccinino F
    Infection; 1983; 11(1):31-2. PubMed ID: 6840865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
    Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
    Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.
    Chu CM; Liaw YF
    Gastroenterology; 1987 Jan; 92(1):220-5. PubMed ID: 3536652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological significance of HBeAg subtypes (HBeAg/1 and HBeAg/2) in patients with type B hepatitis.
    Kanno A; Ohori H; Matsuda K; Nakayama H; Miyazaki Y; Ishii M; Suzuki H; Ohtsuki M; Goto Y
    Hepatology; 1987; 7(1):15-9. PubMed ID: 3100410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.